Early postmenopausal women who receive zoledronate every 5 years have a lower risk for morphometric vertebral fractures than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback